144 filed Jun 29, 2026 at 15:06 ET
Former director Saira Ramasastry filed a Form 144 on June 29, 2026, indicating intent to sell 16,000 shares of Vir Biotechnology (VIR) with an approximate market value of $165,139. The sale follows a stock option exercise and represents a routine diversification move by a former board member, not a current executive. Given the small size relative to VIR's $1.7B market cap and the insider's former-director status, the signal is minimal.